Answers are grounded in this paper and cite their sources.
A 5-year-old neutered female toy Poodle chronically treated with systemic and topical azoles to control recurrent Malassezia dermatitis/otitis was presented because of the loss of treatment efficacy. Minimum Inhibitory Concentrations (MICs) obtained in vitro for various azoles (especially itraconazole and ketoconazole) against Malassezia strains isolated from the dog were increased by several-fold compared with MICs obtained for control isolates. These results reinforced the assumption based on clinical observation, i.e. the development of azole resistance.
No takes yet. Share an insight, caveat, or question.
Angileri et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: